The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
AMP-Activated Protein Kinase Functionally Phosphorylates Endothelial Nitric Oxide Synthase Ser633
Open accessAbstract
Endothelial nitric oxide synthase (eNOS) plays a central role in maintaining cardiovascular homeostasis by controlling NO bioavailability. The activity of eNOS in vascular endothelial cells (ECs) largely depends on posttranslational modifications, including phosphorylation. Because the activity of AMP-activated protein kinase (AMPK) in ECs can be increased by multiple cardiovascular events, we studied the phosphorylation of eNOS Ser633 by AMPK and examined its functional relevance in the mouse models. Shear stress, atorvastatin, and adiponectin all increased AMPK Thr172 and eNOS Ser633 phosphorylations, which were abolished if AMPK was pharmacologically inhibited or genetically ablated. The constitutively active form of AMPK or an AMPK agonist caused a sustained Ser633 phosphorylation. Expression of gain-/loss-of-function eNOS mutants revealed that Ser633 phosphorylation is important for NO production. The aorta of AMPKalpha2(-/-) mice showed attenuated atorvastatin-induced eNOS phosphorylation. Nano-liquid chromatography/tandem mass spectrometry (LC/MS/MS) confirmed that eNOS Ser633 was able to compete with Ser1177 or acetyl-coenzyme A carboxylase Ser79 for AMPKalpha phosphorylation. Nano-LC/MS/MS confirmed that eNOS purified from AICAR-treated ECs was phosphorylated at both Ser633 and Ser1177. Our results indicate that AMPK phosphorylation of eNOS Ser633 is a functional signaling event for NO bioavailability in ECs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increasing evidence suggests that AMPK is essential in maintaining NO bioavailability.”
From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [163]
In the citing paper
“AMPK is activated and in turn acts as a direct activator of eNOS by phosphorylating its Ser1177 residue [163].”
From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [163]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., Reddy, H., Caivano, M., & Cohen, P. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510095 · Cited by 4,366
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D. J., Gratton, J., McCabe, T. J. D., Fontana, J. T., Fujio, Y., Walsh, K. X., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,616
AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling
Towler, M. C., & Hardie, D. G. (2007) · Circulation Research · doi:10.1161/01.res.0000256090.42690.05 · Cited by 1,262
Corton, J. M., Gillespie, J. G., Hawley, S. A., & Hardie, D. G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20498.x · Cited by 1,232
Endothelial Function: Cardiac Events
Lerman, A., & Zeiher, A. M. (2005) · Circulation · doi:10.1161/01.cir.0000153339.27064.14 · Cited by 1,096
Mammalian nitric oxide synthases
Stuehr, D. J. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00016-x · Cited by 996
Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial Cells
Chen, H., Montagnani, M., Funahashi, T., Shimomura, I., & Quon, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307878200 · Cited by 995
Flagged first, then by citations
1 of the 46 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 264
Sung, J. Y., & Choi, H. C. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.04.052 · Cited by 45
Wang, Q., Wu, S., Zhu, H., Ding, Y., Dai, X., Ouyang, C., Han, Y.-M., Xie, Z., & Zou, M.-H. (2017) · Autophagy · doi:10.1080/15548627.2016.1263776 · Cited by 45
Alterations in endothelial nitric oxide synthase activity and their relevance to blood pressure
Suvorava, T., Metry, S., Pick, S., & Kojda, G. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115256 · Cited by 49
Perivascular Adipose Tissue Inhibits Endothelial Function of Rat Aortas via Caveolin-1
Lee, M. H.-H., Chen, S.-J., Tsao, C., & Wu, C.-C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099947 · Cited by 45
“They regulate the phosphorylate sites of eNOS, e.g., Thr495, Ser1177, Ser633, Ser615 and Ser114 residues [38].”
BackgroundSu, K., Yu, Y., Hou, H., Zhao, J., Kou, Y. R., Cheng, L., Shyue, S., & Lee, T. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.23052 · Cited by 45
“Chen et al., 2009; Stahmann et al., 2010).”
BackgroundProtective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence
Mangoni, A. A., Zinellu, A., Sotgia, S., Carru, C., Piga, M., & Erre, G. L. (2017) · Mediators of Inflammation · doi:10.1155/2017/9632846 · Cited by 47
Endothelial Gata5 transcription factor regulates blood pressure
Messaoudi, S., He, Y., Gutsol, A. A., Wight, A. E., Hébert, R., Vilmundarson, R. O., Makrigiannis, A. P., Chalmers, J. P., Hamet, P., Tremblay, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms9835 · Cited by 44
Morus alba extract modulates blood pressure homeostasis through eNOS signaling
Carrizzo, A., Ambrosio, M., Damato, A., Madonna, M., Storto, M., Capocci, L., Campiglia, P., Sommella, E., Trimarco, V., Rozza, F., et al. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600233 · Cited by 43
García‐Prieto, C. F., Pulido-Olmo, H., Ruiz‐Hurtado, G., Gil‐Ortega, M., Aránguez, I., Rubio, M. Á., Ruiz‐Gayo, M., Somoza, B., & Fernández‐Alfonso, M. S. (2014) · Vascular Pharmacology · doi:10.1016/j.vph.2014.12.001 · Cited by 44
Dai, X., Ding, Y., Liu, Z., Zhang, W., & Zou, M. (2016) · Circulation Research · doi:10.1161/circresaha.116.309463 · Cited by 41
SIRT1: A Novel Protective Molecule in Pre-eclampsia
Liu, Z., Wang, C., Pei, J., Li, M., & Gu, W. (2022) · International Journal of Medical Sciences · doi:10.7150/ijms.73012 · Cited by 40
“SIRT1 can directly deacetylate or phosphorylate eNOs, or indirectly stimulate eNOs activity by FOXOs and AMPK pathway [84], which might participate in the pathogenesis of pre-eclampsia.”
BackgroundXu, M.-J., Song, P., Shirwany, N., Liang, B., Xing, J., Viollet, B., Wang, X., Zhu, Y., & Zou, M.-H. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.227991 · Cited by 39
Pravastatin accelerates ischemia-induced angiogenesis through AMP-activated protein kinase
Izumi, Y., Shiota, M., Kusakabe, H., Hikita, Y., Nakao, T., Nakamura, Y., Muro, T., Miura, K., Yoshiyama, M., & Iwao, H. (2009) · Hypertension Research · doi:10.1038/hr.2009.77 · Cited by 39
McCormick, M. E., Goel, R., Fulton, D. J., Oess, S., Newman, D. K., & Tzima, E. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.216200 · Cited by 39
Chen, Z. B., Martin, M., Zhao, L., & Shyy, J. Y.-J. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000107 · Cited by 40
Miragem, A. A., & de Bittencourt, P. I. H. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx020 · Cited by 39
PKA-mediated eNOS phosphorylation in the protection of ischemic preconditioning against no-reflow
Li, X., Cheng, Y., Yang, Y.-J., Meng, X., Zhao, J., Zhang, H., Wu, Y., You, S.-J., & Wu, Y. (2012) · Microvascular Research · doi:10.1016/j.mvr.2012.04.002 · Cited by 39
Metformin Treatment Improves Erectile Function in an Angiotensin II Model of Erectile Dysfunction
Labazi, H., Wynne, B. M., Tostes, R. C., & Webb, R. C. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12245 · Cited by 38
Omae, T., Nagaoka, T., Tanano, I., & Yoshida, A. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-11756 · Cited by 38
“Most previous reports have shown that adiponectin phosphorylated eNOS for 5 to 30 minutes in HUVECs(20) and BAECs.(19,47) Moreover, AMPK, which is involved in NO generation in response to adiponectin as mentioned previously, is phosphorylated by adiponectin within 15 to 30 minutes(20) and 15 to 120 minutes in HUVECs.”
BackgroundInfluentialKwon, H. J., Rhim, J. H., Jang, I., Kim, G.-E., Park, S. C., & Yeo, E. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.4.025 · Cited by 37
“Because AMPK phosphorylates endothelial NOS on Ser633 and control NO bioavailability in vascular endothelial cells (ECs) (Chen et al., 2009), and S-nitrosylated GAPDH can be translocated to the nucleus under diverse apoptotic stimuli (Hara et al.”
BackgroundHuang, X., Fan, R., Lu, Y., Chang, Y., Xu, X., Zhang, X., Liu, P., Yan, S., Chen, C., & Wang, L. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3272-9 · Cited by 38
“[31] also reported AMPK phosphorylation of eNOS Ser633 is a functional signalling event for NO bioavailability in vascular endothelial cells.”
BackgroundEndogenous Cardioprotective Agents: Role in Pre and Postconditioning
Penna, C. R. R., Granata, R., Tocchetti, C. G., Gallo, M. P., Alloatti, G., & Pagliaro, P. (2015) · Current Drug Targets · doi:10.2174/1389450116666150309115536 · Cited by 37
“In the endothelial cells the AdipoR 1 and 2 activation induces NO-dependent vasodilatation and this effect is mediated by via AMPK-mediated phosphorylation of eNOS in two sites (Ser1177 and Ser633) [104].”
BackgroundMetformin and the Liver: Unlocking the Full Therapeutic Potential
Perazza, F., Leoni, L., Colosimo, S., Musio, A., Bocedi, G., D’Avino, M., Agnelli, G., Nicastri, A., Rossetti, C., Sacilotto, F., et al. (2024) · Metabolites · doi:10.3390/metabo14040186 · Cited by 39
AMPK and Pulmonary Hypertension: Crossroads Between Vasoconstriction and Vascular Remodeling
Zhao, Q., Song, P., & Zou, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.691585 · Cited by 37
How to protect liver graft with nitric oxide
Abdennebi, H. B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i24.2879 · Cited by 39
Progesterone Attenuates SIRT1-Deficiency-Mediated Pre-Eclampsia
Pei, J., Liu, Z., Wang, C., Chu, N., Liu, L., Tang, Y., Liu, H., Xiang, Q., Cheng, H., Li, M., et al. (2022) · Biomolecules · doi:10.3390/biom12030422 · Cited by 36
He, M., Martin, M., Marin, T., Chen, Z., & Gongol, B. (2020) · APL Bioengineering · doi:10.1063/1.5129563 · Cited by 35
Liu, Y., Oh, S.-J., Chang, K.-H., Kim, Y.-G., & Lee, M. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.009 · Cited by 35
“Activation of the eNOS-NO/sGC-cGMP/PKG signaling axis by AICAR and its involvement in antiaggregatory effect were tested in platelets based on previous findings that activated AMPK phosphorylates and stimulates eNOS directly [8,10,24].”
Almabrouk, T. A. M., Ugusman, A., Katwan, O. J., Salt, I. P., & Kennedy, S. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13633 · Cited by 35
“, 2006) and Ser(633) (Chen et al., 2009) to increase NO production and vascular relaxation (Morrow et al.”
BackgroundJung, S.-B., Kwon, S. K., Kwon, M., Nagar, H., Jeon, B. H., Irani, K., Yoon, S. H., & Kim, C. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.049 · Cited by 36
“AMPK activates NOS by phosphorylation of eNOS at ser633 [15,16].”
BackgroundLiu, X., Peyton, K. J., Shebib, A. R., Wang, H., & Durante, W. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.016 · Cited by 34
The Role of Adiponectin in Maintaining Metabolic Homeostasis
Adıyaman, S. C., Özer, M., Saydam, B. Ö., & Akıncı, B. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815666190702155733 · Cited by 36
Chen, M., Yi, B., Zhu, N., Wei, X., Zhang, G., Huang, S., & Sun, J. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv250 · Cited by 34
“been shown to be phosphorylated at residue Ser-633 and this phosphorylation has been shown to augment eNOS activity under both basal and stimulated conditions, hence playing an important role in the response of ECs to shear stress and statin treatment.(10) Although protein kinase A (PKA), extracellular signal-regulate…”
BackgroundResultIkeda, Y., Aihara, K., Yoshida, S., Iwase, T., Tajima, S., Izawa‐Ishizawa, Y., Kihira, Y., Ishizawa, K., Tomita, S., Tsuchiya, K., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.353532 · Cited by 33
Huang, J., Cai, C., Zheng, T., Wu, X., Wang, D., Zhang, K., Xu, B., Yan, R., Gong, H., Zhang, J., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314172 · Cited by 33
Omae, T., Nagaoka, T., & Yoshida, A. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16447 · Cited by 33
SNRK (Sucrose Nonfermenting 1-Related Kinase) Promotes Angiogenesis In Vivo
Lu, Q., Xie, Z., Yan, C., Ding, Y., Ma, Z., Wu, S., Qiu, Y., Cossette, S. M., Bordas, M. L., Ramchandran, R., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309834 · Cited by 34
Cheng, P., Lee, H.-C., Lu, P., Chen, H., Lai, C.-C., Sun, G., Yeh, T., Hsiao, M., Lin, Y., Liu, C.-P., et al. (2016) · Scientific Reports · doi:10.1038/srep25342 · Cited by 32
Adiponectin and insulin cross talk: The microvascular connection
Zhao, L., Fu, Z., & Liu, Z. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.08.001 · Cited by 34
“[29] Chen Z, Peng IC, Sun W, et al.”
BackgroundSon, M., Oh, S., Lee, H. S., Chung, D.-M., Jang, J. T., Jeon, Y., Choi, C. H., Park, K. Y., Son, K. H., & Byun, K. (2019) · Nutrients · doi:10.3390/nu11112795 · Cited by 31
“In EC, AMPK activates the phosphorylation of eNOS which leads to the production of NO [77,80] through protein kinase B (Akt) [81] or PI3K-Akt”
BackgroundNatani, S., Dhople, V. M., Parveen, A., Sruthi, K. K., Khilar, P., Bhukya, S., & Ummanni, R. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119085 · Cited by 30
Gómez, H., Rio‐Pertuz, G. D., Priyanka, P., Manrique-Caballero, C. L., Chang, C.-C. H., Wang, S., Liu, Q., Zuckerbraun, B. S., Murugan, R., Angus, D. C., et al. (2022) · Critical Care Medicine · doi:10.1097/ccm.0000000000005468 · Cited by 31
“Metformin and AMPK activation improve endothelial function, reducing capillary leak (11) and inducible nitric oxide synthase (38), and increasing endothelial nitric oxide synthase activity (39), potentially improving vascular tone and microvascular function.”
BackgroundAMPK and the Challenge of Treating Hypoxic Pulmonary Hypertension
Flores, K., Siqués, P., Brito, J., & Arribas, S. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116205 · Cited by 30
Mushtaq, Z., Imran, M., Hussain, M., Saeed, F., Imran, A., Umar, M., Abdelgawad, M. A., El-Ghorab, A. H., Ahmed, A., Alsagaby, S. A., et al. (2023) · International Journal of Food Properties · doi:10.1080/10942912.2023.2209702 · Cited by 33
“[59] AMPKα has been found to regulate the TGF-β and MAPK signaling pathways in myocytes whereas Asiatic acid reversed these changes.”
BackgroundTseng, S., Chao, T., Li, Y., Liu, P., Lee, C., Cho, C.-L., Wu, H., & Chen, J.-H. (2015) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.10.103 · Cited by 30
Jia, F., Wu, C., Chen, Z., & Lü, G. (2011) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00287.x · Cited by 30
“Atorvastatin is known to have positive effects on the phosphorylation of AMPK in endothelial cells [26].”
BackgroundAMPK activation—protean potential for boosting healthspan
McCarty, M. F. (2013) · AGE · doi:10.1007/s11357-013-9595-y · Cited by 30
GPR39 agonist TC-G 1008 promotes osteoblast differentiation and mineralization in MC3T3-E1 cells
Chai, X., Zhang, W., Chang, B., Feng, X., Song, J., Li, L., Yu, C., Zhao, J., & Si, H. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1649270 · Cited by 29
“Previous research has reported that AMPK-mediated Runx-2 induction promotes osteoblast differentiation in MC3T3-E1 cells [19].”
BackgroundPyla, R., Osman, I., Pichavaram, P., Hansen, P., & Segar, L. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.024 · Cited by 30
“In vascular endothelium, metformin activates AMP-activated protein kinase (AMPK), which phosphorylates endothelial nitric oxide synthase thereby increasing the production of nitric oxide, a potent vasodilator [10,11].”
Cyclin-Dependent Kinase 5 Phosphorylates Endothelial Nitric Oxide Synthase at Serine 116
Cho, D., Seo, J., Park, J., Jo, C., Choi, Y. J., Soh, J., & Jo, I. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.140210 · Cited by 29
Cao, W., Cui, J., Li, S., Zhang, D., Guo, Y., Li, Q., Luan, Y., & Liu, X. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.05.021 · Cited by 29
Zhang, J., Kong, X., Wang, Z., Gao, X., Ge, Z., Gu, Y., Ye, P., Chao, Y., Zhu, L., Li, X., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801869rrr · Cited by 28
Vascular AMPK as an attractive target in the treatment of vascular complications of obesity
García‐Prieto, C. F., Gil‐Ortega, M., Aránguez, I., Ortiz-Besoain, M., Somoza, B., & Fernández‐Alfonso, M. S. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.02.017 · Cited by 28
Globular adiponectin controls insulin-mediated vasoreactivity in muscle through AMPKα2
de Boer, M. P., Meijer, R. I., Richter, E. A., Amerongen, G. P. V. N., Sipkema, P., van Poelgeest, E. M., Aman, J., Kokhuis, T. J. A., Koolwijk, P., van Hinsbergh, V. W. M., et al. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.09.002 · Cited by 27
Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate
Mangoni, A. A., Tommasi, S., Zinellu, A., Sotgia, S., Carru, C., Piga, M., & Erre, G. L. (2018) · Drugs in Context · doi:10.7573/dic.212557 · Cited by 27
Targeting senescent cells for vascular aging and related diseases
Ding, Y.-N., Wang, H.-Y., Chen, H., & Liu, D. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.08.009 · Cited by 30
Zippel, N., Loot, A. E., Stingl, H., Randriamboavonjy, V., Fleming, I., & Fißlthaler, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092753 · Cited by 27
“AMPK activation was also linked with the phosphorylation of eNOS on Ser1177 in isolated endothelial cells [13,37,53], but contrasted somewhat with the lack of effect on endothelium-dependent vascular reactivity [27].”
BackgroundWhen Metabolism Rules Perfusion
Schulz, E., Schuhmacher, S., & Münzel, T. F. (2009) · Circulation Research · doi:10.1161/circresaha.109.194274 · Cited by 27
Methotrexate and cardiovascular prevention: an appraisal of the current evidence
Mangoni, A. A., Sotgia, S., Zinellu, A., Carru, C., Pintus, G., Damiani, G. B., Erre, G. L., & Tommasi, S. (2023) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/17539447231215213 · Cited by 31
Brachial artery characteristics and micro‐vascular filtration capacity in rock climbers
Thompson, E. B., Farrow, L., Hunt, J. E. A., Lewis, M. P., & Ferguson, R. A. (2014) · European Journal of Sport Science · doi:10.1080/17461391.2014.940560 · Cited by 27
Schwer, C. I., Lehane, C., Guelzow, T., Zenker, S., Strosing, K. M., Spassov, S. G., Erxleben, A., Heimrich, B., Buerkle, H., & Humar, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077258 · Cited by 26
“Additionally, AMPK has been associated with induction of eNOS [32], an enzyme that promotes vasodilatation, increases regional blood flow in ischemic brain tissue, and reduces infarct volume [33].”
BackgroundLobato, N. S., Filgueira, F. P., Prakash, R., Giachini, F. R. C., Ergul, A., de Carvalho, M. H. C., Webb, R. C., Tostes, R. C., & Fortes, Z. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063449 · Cited by 26
“Recent studies indicate that cannabinoid compounds activate the AMPK pathway in tissues that control energy homeostasis [56].”
BackgroundFasting as Medicine: Mitochondrial and Endothelial Rejuvenation in Vascular Aging
Milan, M., Troyano‐Rodriguez, E., Ihuoma, J., Negri, S., Rudraboina, R., Kosmider, A., Awasthi, S., Balasubramanian, P., Conley, S. M., Yabluchanskiy, A., et al. (2026) · Aging Cell · doi:10.1111/acel.70372 · Cited by 25
“Activation of AMPK enhances endothelial NO bioavailability (Chen et al. 2009), stimulates mitochondrial biogenesis, promotes autophagy and mitophagy (Rodriguez et al. 2021), and reduces oxidative stress (Jansen et al. 2021).”
The Role of Sirtuin-1 (SIRT1) in the Physiology and Pathophysiology of the Human Placenta
Wątroba, M., Szewczyk, G., & Szukiewicz, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216210 · Cited by 29
“SIRT1 may directly deacetylate eNOs, or stimulate eNOs activity indirectly by affecting FoxO proteins and AMPK-dependent signaling pathways [156], which can participate in PE pathogenesis.”
BackgroundFan, Y., Yang, S., Zhang, X.-K., Cao, Y., & Huang, Y. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12014 · Cited by 25
Yoshitomi, H., Zhou, J., Nishigaki, T., Li, W., Liu, T., Wu, L., & Gao, M. (2020) · Phytotherapy Research · doi:10.1002/ptr.6685 · Cited by 24
“AMPK, which is activated leading to the phospharalytion and activation of eNOS, has been reported to enhance NO production and vasodilatory effect in vascular endothelial cells (Chen et al., 2009; Kanazawa, Yamaguchi, Yano, Yamauchi, & Sugimoto, 2008; Li et al., 2008).”
BackgroundEffects and Mechanisms of Five Psoralea Prenylflavonoids on Aging-Related Diseases
Zhou, Y., Zhu, L., Yuan, Y., Ling, S., & Xu, J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2128513 · Cited by 24
“Our multiple results indicate (Figure 4) that AMPK-mediated cardiovascular protection of bavachalcone can include regulating mitochondrial biogenesis [65], delaying cell senescence [66], activating eNOS, MnSOD and PGC-1α activity and expression [67, 68], and promoting EPC differentiation [69], which presents consisten…”
ResultZhao, Y., Ye, S., Lin, J., Liang, F., Chen, J., HU, J. L., Chen, K., Fang, Y., Chen, X., Xiong, Y., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.680351 · Cited by 24
Type 2 Diabetes and Vascular Endothelial Dysfunction
Torimoto, K., Okada, Y., & Tanaka, Y. (2018) · Journal of UOEH · doi:10.7888/juoeh.40.65 · Cited by 24
de Araújo, S., de Oliveira, A. P., Sousa, F. B. M., de Souza, L. K. M., Pacheco, G., Filgueiras, M. D. C., Nicolau, L. A. D., Brito, G. A. D. C., Cerqueira, G. S., Silva, R. O., et al. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.05.008 · Cited by 23
EDF-1 contributes to the regulation of nitric oxide release in VEGF-treated human endothelial cells
Leidi, M., Mariotti, M., & Maier, J. A. M. (2010) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.05.001 · Cited by 23
Hu, S., Pi, Q., Xu, X., Yan, J., Guo, Y., Tan, W., He, A., Cheng, Z., Luo, S., & Xia, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118606 · Cited by 22
Ward, N. C., Chen, K., Li, C., Croft, K. D., & Keaney, J. F. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05509.x · Cited by 22
“The serine-1177 residue is typically seen as an activation site that is required for normal eNOS function.(13) There were no changes observed at serine-633; however, phosphorylation of threonine-495 increased over time.”
BackgroundRegulation of cardiac miR-208a, an inducer of obesity, by rapamycin and nebivolol
Gul, R., Mahmood, A., Luck, C., Lum‐Naihe, K., Alfadda, A. A., Speth, R. C., & Pulakat, L. (2015) · Obesity · doi:10.1002/oby.21227 · Cited by 22
“In addition to being a b1-AR blocker, Neb is known to act as an agonist of b3-AR and also to activate endothelial nitric oxide synthase (eNOS) and AMP kinase (27-31).”
Zhang, X., Zhou, C., Miao, L., Tan, Y., Zhou, Y., Cheong, M. S., Huang, Y., Wang, Y., Yu, H., & Cheang, W. S. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4722797 · Cited by 21
“AMPK activation stimulates eNOS and increases NO bioavailability [23].”
BackgroundRAMP2-AS1 Regulates Endothelial Homeostasis and Aging
Lai, C., Chen, A. T., Burns, A. B., Sriram, K., Luo, Y., Tang, X., Branciamore, S., O’Meally, D., Chang, S.-L., Huang, P., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.635307 · Cited by 20
Jia, F., Wu, C., Chen, Z., & Lü, G. (2011) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6277-1 · Cited by 20
“AMPK could phosphorylate eNOS Ser633 to regulate NO bioavailability [ 16 ], and mediate some cardiovascular protective effects of drugs such as atorvastatin through eNOS activation [17].”
BackgroundDuarte-Silva, E. P., Araújo, S. M. D. R., de Oliveira, W. H., Lós, D. B., Bonfanti, A. P., Peron, G., Thomaz, L. D. L., Verinaud, L. M. C., & Peixoto, C. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.671511 · Cited by 18
“It is worthy to mention that activated AMPK phosphorylates and activates eNOS, leading to NO production, which in turn activates AMPK (41, 43).”
BackgroundAdvances in endothelial shear stress proteomics
Firasat, S., Hecker, M., Binder, L., & Asif, A. R. (2014) · Expert Review of Proteomics · doi:10.1586/14789450.2014.933673 · Cited by 21
“eNOS activity is regulated by phosphorylation/ dephosphorylation of serine (Ser) and threonine residues by protein kinases/phosphatases [56,57].”
BackgroundSartoretto, J. L., Kalwa, H., Shiroto, T., Sartoretto, S., Pluth, M. D., Lippard, S. J., & Michel, T. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044627 · Cited by 19
“We and others have previously reported that AMPK regulates eNOS in endothelial cells [21,22].”
Hardie, D. G. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00073-5 · Cited by 19
Hauger, P. C., & Hordijk, P. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116047 · Cited by 21
“Further investigations revealed that shear stress-activated AMPK phosphorylates eNOS at Ser633 and Ser1177 [45,71].”
BackgroundOmics‐based approaches to understand mechanosensitive endothelial biology and atherosclerosis
Simmons, R. D., Kumar, S., Thabet, S., Sur, S., & Jo, H. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1344 · Cited by 18
“Furthermore, AMPK can directly phosphorylate eNOS at Ser633 in response to shear stress, statins, and adiponectin and is crucial for NO bioavailability.(213) AMPK not only regulates eNOS directly but also regulates the key mechanosensitive transcription factor KLF2 which also regulates eNOS.”
BackgroundRittig, N. F., Aagaard, N. K., Villadsen, G. E., Sandahl, T. D., Jessen, N., Grønbæk, H., & George, J. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16460 · Cited by 17
Inhibition of sphingomyelinase attenuates diet – Induced increases in aortic stiffness
Habibi, J., DeMarco, V. G., Hulse, J. L., Hayden, M. R., Whaley‐Connell, A. T., Hill, M. A., Sowers, J. R., & Jia, G. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.03.006 · Cited by 17
Gadanec, L. K., Qaradakhi, T., McSweeney, K. R., Matsoukas, J., Apostolopoulos, V., Burrell, L. M., & Zulli, A. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115397 · Cited by 16
Regulation of Overnutrition-Induced Cardiac Inflammatory Mechanisms by nebivolol
Gul, R., DeMarco, V. G., Sowers, J. R., Whaley‐Connell, A. T., & Pulakat, L. (2012) · Cardiorenal Medicine · doi:10.1159/000339565 · Cited by 16
Devika, N. T., Amresh, P., Hassan, M. I., & Ali, B. M. J. (2014) · Journal of Molecular Modeling · doi:10.1007/s00894-014-2470-7 · Cited by 16
“Experimental observations reported in the literature suggest that S633 functions as a stimulatory phosphorylation site which is stimulated in response to shear stress [43].”
BackgroundMethotrexate and Cardiovascular Protection: Current Evidence and Future Directions
Mangoni, A. A., Zinellu, A., Sotgia, S., Carru, C., & Erre, G. L. (2017) · Clinical Medicine Insights Therapeutics · doi:10.1177/1179559x17741289 · Cited by 18
N-cadherin coordinates AMP kinase-mediated lung vascular repair
Jian, M., Liu, Y., Li, Q., Wolkowicz, P. E., ALEXEYEV, M. F., Zmijewski, J. W., & Creighton, J. R. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00227.2015 · Cited by 15
Pathological basis of cardiac arrhythmias: vicious cycle of immune-metabolic dysregulation
Wang, S. C., Meng, D., Yang, H.-P., Wang, X., Jia, S., Wang, Y., & Wang, P. (2017) · Cardiovascular Disorders and Medicine · doi:10.15761/cdm.1000158 · Cited by 15
“This proposal is supported by the studies on vascular endothelial cells in mice [30] and human umbilical vein endothelial cells [31].”
ResultSertedaki, E., Veroutis, D., Zagouri, F., Galyfos, G. C., Filis, K., Papalambros, A., Aggeli, K. D., Tsioli, P., Charalambous, G., Zografos, G., et al. (2020) · Current Gerontology and Geriatrics Research · doi:10.1155/2020/8601762 · Cited by 15
Li, X., Song, Y., Han, Y., Wang, D., & Zhu, Y. (2012) · Microcirculation · doi:10.1111/j.1549-8719.2012.00186.x · Cited by 14
“We and other groups previously reported that AMPK-eNOS activation could improve EPC differentiation [2,6,10].”
BackgroundMangoni, A. A., Tommasi, S., Zinellu, A., Sotgia, S., Bassu, S., Piga, M., Erre, G. L., & Carru, C. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191112091700 · Cited by 14
Robillard, S., Trân, K., Lachance, M.-S., Brazeau, T., Boisvert, E., Lizotte, F., Auger‐Messier, M., Boudreault, P., Marsault, É., & Geraldes, P. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1191891 · Cited by 13
“Interestingly, the administration of Pyr-apelin-13 in diabetic mice increased both Ser1177 phosphorylation of eNOS by 3.7-fold (P = 0.0010; reported to GAPDH) or 4.3-fold (P = 0.0224; reported to total eNOS) (Figures 5A,F,G) and Ser633 by 2.5-fold (P = 0.0168; reported to GAPDH) or 2.1-fold (P = 0.0058; reported to to…”
BackgroundInfluentialKidney-specific genetic deletion of both AMPK α-subunits causes salt and water wasting
Lazo‐Fernandez, Y., Baile, G., Meade, P., Torcal, P., Martínez-Gimeno, L., Ibañez, C. R., Bernal, M. L., Viollet, B., & Gimenez-Lopez, I. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00169.2016 · Cited by 15
“In addition, AMPK stimulates vasorelaxation through endothelium-dependent hyperpolarization (19) and the activation of endothelial nitric oxide (NO) synthase (13, 14, 55).”
BackgroundAdams, V., Heiker, J. T., Höllriegel, R., Beck, E. B., Woitek, F. J., Erbs, S., Blüher, M., Stümvoll, M., Beck‐Sickinger, A. G., Schuler, G. C., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.05.056 · Cited by 13
“With respect to the underlying signaling pathways, the involvement of AMP-activated protein kinase (AMPK) in the phosphorylation of eNOS either at position Ser or Ser is proven in the literature [34–36].”
BackgroundSex-Specific Antioxidant and Anti-Inflammatory Protective Effects of AMPK in Cardiovascular Diseases
Strohm, L., Mihaliková, D., Czarnowski, A., Schwaibold, Z., Daiber, A., & Stamm, P. (2025) · Antioxidants · doi:10.3390/antiox14050615 · Cited by 12
“Physiological, pharmacological, and hormonal stimuli, including shear stress, statins, or adiponectin, can directly activate AMPK, leading to eNOS phosphorylation at Ser633/635 and increased NO production [59–62].”
Mishriki, A., Khalifa, A. K., Ibrahim, D. A., Hashem, G., Rashed, L. A., Abdelrahmen, S. S., & Mahmoud, H. (2024) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-024-00669-3 · Cited by 12
“It also regulates endothelial function through boosting endothelial nitric oxide synthase (eNOS) [42, 43].”
BackgroundVascular adenosine monophosphate‐activated protein kinase: Enhancer, brake or both?
Chen, H., Vanhoutte, P. M., & Leung, S. W. S. (2019) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13357 · Cited by 14
Metadata
- Authors
- Chen, Z., Peng, I.-C., Sun, W., Su, M.-I., Hsu, P.-H., Fu, Y., Zhu, Y., DeFea, K., Pan, S., Tsai, M.-D., & Shyy, J. Y.-J.
- Affiliations
- University of California, Riverside (US)
- Venue
- Circulation Research
- Published
- 2009-02-27
- Volume
- 104
- Issue
- 4
- Pages
- 496-505
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC2761102
- OpenAlex
- W1966733021
- Cited by
- 264
- References
- 46
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 8 · 2023: 6 · 2022: 10 · 2021: 17 · 2020: 19 · 2019: 12 · 2018: 13 · 2017: 13 · 2016: 14 · 2015: 22 · 2014: 27 · 2013: 15 · 2012: 26
- FWCI
- 16.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL-77448, R01HL089940, R01HL077448, HL89940)
- National Institute of General Medical Sciences (R01GM066151)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- AMPK, endothelial nitric oxide synthase, eNOS Ser1177 phosphorylation, nitric oxide bioavailability, shear stress, atorvastatin, adiponectin, AMPKα2, vascular endothelial cells, post-translational modification, AICAR
- MeSH terms
- Atorvastatin, Acetyl-CoA Carboxylase, Aminoimidazole Carboxamide, Animals, Cattle, Cells, Cultured, Chromatography, Liquid, Enzyme Activation, Heptanoic Acids, Humans, Mice, Inbred C57BL, Mutation, Nitric Oxide, Phosphorylation, Protein Processing, Post-Translational, Pyrazoles, Pyrimidines, Pyrroles, Ribonucleotides, Serine, Stress, Mechanical, Time Factors, Transfection, Signal Transduction, Mice, Knockout, Hydroxymethylglutaryl-CoA Reductase Inhibitors, RNA Interference, RNA, Small Interfering, Nanotechnology, Endothelial Cells, Protein Kinase Inhibitors, Mice, Adiponectin, Nitric Oxide Synthase Type III, Tandem Mass Spectrometry, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review